Kyro Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Navi Mumbai, Maharashtra, India, established in 2010.
2010 Navi Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About Kyro Pharmaceuticals Private Limited

Kyro Pharmaceuticals Private Limited, a struck off private limited company, was established on 05 August 2010 in Navi Mumbai, Maharashtra, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24100MH2010PTC206265. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Lokendraprasad Chandradev Ojha (Director), Arati Lokendraprasad Ojha (Additional Director). Past directors included Hansraj Chandradev Oza, Pawan Narendrakumar Rajput. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at Flat No. 303, 3Rd Floor, 77, Blue Star, Sector-09 New Panvel, Navi Mumbai, Maharashtra, 410206.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100MH2010PTC206265

  • Registration Number

    206265

  • Incorporation Date

    05 August 2010

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 15 Year, 6 Months
  • Last Filing with ROC 31 Mar 2017
  • Revenue Growth **** %
  • Profit Growth **** 5.90%
  • Ebitda **** 5.90%
  • Total Assets **** %
Company report

Kyro Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kyro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Kyro Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Lokendraprasad Chandradev Ojha Director 05 Aug 2010 Current
Arati Lokendraprasad Ojha Additional Director 27 Sep 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Apr 2018 Past
Pramod Abcsdd Additional Director 27 Sep 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kyro Pharmaceuticals.

Kyro Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.9% increase in profit. The company's net worth witnessed no change by increase of 0%.

Kyro Pharmaceuticals revenue growth over time
Kyro Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
 5.90%
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 5.90%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kyro Pharmaceuticals?

In 2017, Kyro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kyro Pharmaceuticals?

Unlock and access historical data on people associated with Kyro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kyro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyro Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kyro Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Arati Lokendraprasad Ojha was appointed as a Additional Director was appointed as a Additional Director on 27 Sep 2018 & has been associated with this company since 7 years 4 months . was completed.

  • Annual General Meeting

    Progress on Kyro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Kyro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was completed.

  • Director Appointment

    Progress on Lokendraprasad Chandradev Ojha was appointed as a Director was appointed as a Director on 05 Aug 2010 & has been associated with this company since 15 years 6 months . was documented.

  • Company Incorporation

    The activity Kyro Pharmaceuticals Private Limited was registered on 05 Aug 2010 with Roc Mumbai & aged 15 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kyro Pharmaceuticals Private Limited?

The CIN of Kyro Pharmaceuticals Private Limited is U24100MH2010PTC206265.

Where is Kyro Pharmaceuticals Private Limited headquartered?

Kyro Pharmaceuticals Private Limited is headquartered at Flat No. 303, 3Rd Floor, 77, Blue Star, Sector-09 New Panvel, Navi Mumbai, Maharashtra, 410206.

When was Kyro Pharmaceuticals Private Limited incorporated?

Kyro Pharmaceuticals Private Limited was incorporated on 05 August 2010.

Who are the current directors of Kyro Pharmaceuticals Private Limited?

The current directors of Kyro Pharmaceuticals Private Limited are

What is the primary industry of Kyro Pharmaceuticals Private Limited?

The primary industry of Kyro Pharmaceuticals Private Limited is Chemicals.

Is Kyro Pharmaceuticals Private Limited a listed company?

Kyro Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kyro Pharmaceuticals Private Limited?

The authorized capital of Kyro Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available